The future looks brighter than ever for patients, and the science driving it
In the case of drugs like Ozempic, a months supply in the US costs as much as $1,300, while it can cost less than 10% of that in Europe and elsewhere
The GIP receptor component may add additional cardiovascular benefits through effects on endothelial function, though this mechanism is less thoroughly characterized
Start your weight loss journey today
The substantial weight loss achieved with GLP-1 receptor agonists and dual GIP/GLP-1 agonistsapproximately 15% with semaglutide 2.4 mg (Wegovy) and up to 21% with higher doses of tirzepatide (Zepbound) in clinical trialsoccurs primarily through appetite suppression and reduced caloric intake rather than increased metabolic rate
As scientists continue exploring next-generation GLP-1 drugs and metabolic peptides , compounds like UBT251 represent the next evolution in incretin-based research